Evidence map›Paper›PMID 32624629›Full record

ArticleActa histochemica et cytochemica2020

Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine Leukemias.

Kiyomi Mashima, Morio Azuma, Ken Fujiwara, Takashi Inagaki, Iekuni Oh, Takashi Ikeda, Kento Umino, Hirofumi Nakano, Kaoru Morita, Kazuya Sato and 10 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta histochemica et cytochemica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Kiyomi MashimaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Morio AzumaDivision of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan.
Ken FujiwaraDivision of Histology and Cell Biology, Department of Anatomy, Jichi Medical University, Tochigi, Japan.
Takashi InagakiDivision of Forensic Medicine, Department of Anatomy, Jichi Medical University, Tochigi, Japan.
Iekuni OhDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Takashi IkedaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kento UminoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Hirofumi NakanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kaoru MoritaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kazuya SatoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Daisuke MinakataDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Ryoko YamasakiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Masahiro AshizawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Chihiro YamamotoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Shin-Ichiro FujiwaraDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kaoru HatanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Ken OhmineDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kazuo MuroiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Nobuhiko OhnoDivision of Histology and Cell Biology, Department of Anatomy, Jichi Medical University, Tochigi, Japan.
Yoshinobu KandaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Jichi Medical University · JPJichi Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemias are refractory hematopoietic malignancies, for which the development of new therapeutic agents requires

Indexed as

immunohistochemistryleukemialeukemia cell linemouse model

Identifiers

PMID32624629
PMCPMC7322163
OpenAlexW3023835318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.